中國交通建設(01800.HK):已贖回11億美元非次級擔保永續證券 4月29日撤回上市地位
格隆匯4月22日丨中國交通建設(01800.HK)公佈,有關11億美元非次級擔保永續證券,發行人於2020年3月19日發出通知,告知信託人、主要付款代理及證券持有人其有意於2020年4月21日贖回全部未到期票據。
發行人已於贖回日期按本金額(連同截至贖回日期(但不包括該日)的應計但未支付票息)贖回本金額合計為11億美元的全部未到期證券。
證券已於贖回完成後註銷。仍未到期證券的本金額合計為零。因此,發行人已向聯交所申請撤回證券上市。自聯交所撤回上市預期將於2020年4月29日營業時間結束後生效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.